Mark G. Edwards, Director at ACELRX PHARMACEUTICALS INC (ACRX), bought 15,000 shares at $3.15 ($47K) on 2016-05-11, disclosed to the SEC on 2016-05-12.
Open-market purchase of $47k ACRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.25 | 5,000 | $16K | 34.4% |
| 2 | $3.15 | 5,000 | $16K | 33.3% |
| 3 | $3.05 | 5,000 | $15K | 32.3% |
| Total | $3.15 avg | 15,000 | $47K | 100% |
| Filing → |
| ACRX | BUY | 2019-03-12 | $114K | — | Filing → |
| ACRX | BUY | 2018-11-15 | $58K | — | Filing → |
| ACRX | BUY | 2018-08-08 | $15K | — | Filing → |